SURVIVAL EFFECT OF PALLIATIVE RADIOTHERAPY IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER DEVELOPING OLIGO-PROGRESSION UNDER ANTIANDROGEN TREATMENT/ANTIANDROJEN TEDAVISI ALTINDA OLIGO-PROGRESYON GELISEN METASTATIK KASTRASYONA DIRENCLI PROSTAT KANSERLI HASTALARDA METASTAZA YONELIK VUCUT RADYOTERAPISININ SAGKALIM ETKISI

Objective: Androgen pathway inhibitors have a significant impact on the treatment of prostate cancer. The treatment approach is controversial in patients who develop oligo-progression under anti-androgen therapy. This study aimed to investigate the effects of metastasis-directed stereotactic body ra...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	İstanbul Tıp Fakültesi dergisi = Journal of the Istanbul Faculty of Medicine 2023-06, Vol.86 (2), p.117
Hauptverfasser:	Aydin, Sabin Goktas, Kutlu, Yasin, Muglu, Harun, Acikgoz, Ozgur, Aydin, Ahmet, Bilici, Ahmet, Olmez, Omer Fatih, Unal, Dilek, Karci, Ebru, Yildiz, Ozcan
Format:	Artikel
Sprache:	eng
Schlagworte:	Androgen suppression therapy Antiandrogens Cancer patients Care and treatment Development and progression Metastasis Palliative treatment Patient outcomes Prostate cancer Radiotherapy Testosterone
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Objective: Androgen pathway inhibitors have a significant impact on the treatment of prostate cancer. The treatment approach is controversial in patients who develop oligo-progression under anti-androgen therapy. This study aimed to investigate the effects of metastasis-directed stereotactic body radiotherapy (SBRT) on survival in the first-line setting of patients with metastatic castration-resistant prostate cancer who continued the antiandrogen therapy after oligo-progression. Materials and Methods: Fifty-seven metastatic castration-resistant (serum testosterone
ISSN:	1305-6433
DOI:	10.26650/IUITFD.1211556